Qiagen NV (Qiagen NV) Price-to-Tangible-Book : 11.29 (As of Apr. 26, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Price-to-Tangible-Book?

As of today (2024-04-26), Qiagen NV's share price is $41.08. Qiagen NV's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $3.64. Hence, Qiagen NV's Price to Tangible Book Ratio of today is 11.29.

The historical rank and industry rank for Qiagen NV's Price-to-Tangible-Book or its related term are showing as below:

QGEN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 11.29 Med: 113.03 Max: 243.41
Current: 11.29

During the past 13 years, Qiagen NV's highest Price to Tangible Book Ratio was 243.41. The lowest was 11.29. And the median was 113.03.

QGEN's Price-to-Tangible-Book is ranked worse than
90.53% of 169 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.41 vs QGEN: 11.29

A closely related ratio is called PB Ratio. As of today, Qiagen NV's share price is $41.08. Qiagen NV's Book Value per Sharefor the quarter that ended in Dec. 2023 was $17.20. Hence, Qiagen NV's P/B Ratio of today is 2.39.

Qiagen NV Price-to-Tangible-Book Historical Data

The historical data trend for Qiagen NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Price-to-Tangible-Book Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

106.70

19.95

12.31

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															19.95	20.06	17.21	12.89	12.31

Competitive Comparison of Qiagen NV's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Qiagen NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Price-to-Tangible-Book falls into.

Qiagen NV Price-to-Tangible-Book Calculation

Qiagen NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	41.08	/	3.638
	=	11.29

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Qiagen NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives